Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 165 | 2024 | 5146 | 15.670 |
Why?
|
Waldenstrom Macroglobulinemia | 105 | 2022 | 1073 | 15.630 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 18 | 2024 | 179 | 5.710 |
Why?
|
Bone Marrow | 46 | 2023 | 2911 | 4.310 |
Why?
|
Receptors, CXCR4 | 20 | 2021 | 727 | 4.210 |
Why?
|
Boronic Acids | 47 | 2015 | 915 | 3.390 |
Why?
|
Pyrazines | 47 | 2015 | 1201 | 3.000 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 43 | 2023 | 11742 | 2.210 |
Why?
|
Antineoplastic Agents | 55 | 2024 | 13639 | 1.970 |
Why?
|
MicroRNAs | 25 | 2024 | 3816 | 1.970 |
Why?
|
Paraproteinemias | 7 | 2022 | 248 | 1.920 |
Why?
|
Bone Marrow Cells | 20 | 2022 | 2416 | 1.840 |
Why?
|
Gene Expression Regulation, Neoplastic | 28 | 2024 | 8547 | 1.820 |
Why?
|
Neoplastic Cells, Circulating | 7 | 2023 | 946 | 1.760 |
Why?
|
Tumor Microenvironment | 27 | 2024 | 3877 | 1.710 |
Why?
|
Mice, SCID | 28 | 2021 | 2626 | 1.690 |
Why?
|
Plasma Cells | 16 | 2024 | 599 | 1.640 |
Why?
|
Immunoglobulin M | 21 | 2022 | 1527 | 1.590 |
Why?
|
Disease Progression | 43 | 2024 | 13506 | 1.470 |
Why?
|
Sirolimus | 14 | 2016 | 1533 | 1.470 |
Why?
|
Cell Adhesion | 23 | 2021 | 3087 | 1.400 |
Why?
|
Chemokine CXCL12 | 9 | 2015 | 454 | 1.400 |
Why?
|
Cell Proliferation | 29 | 2021 | 10445 | 1.250 |
Why?
|
Lymphoproliferative Disorders | 7 | 2016 | 531 | 1.240 |
Why?
|
Protein Kinase Inhibitors | 16 | 2021 | 5671 | 1.220 |
Why?
|
Bone Marrow Neoplasms | 4 | 2017 | 101 | 1.130 |
Why?
|
Antibodies, Monoclonal | 27 | 2018 | 9177 | 1.120 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 19 | 2014 | 694 | 1.110 |
Why?
|
Indoles | 6 | 2014 | 1833 | 1.110 |
Why?
|
Humans | 320 | 2024 | 761504 | 1.080 |
Why?
|
Neoplasm Proteins | 9 | 2019 | 3617 | 1.080 |
Why?
|
Stromal Cells | 15 | 2021 | 1330 | 1.070 |
Why?
|
Osteoblasts | 6 | 2018 | 1143 | 0.980 |
Why?
|
Hematopoietic Stem Cell Transplantation | 17 | 2022 | 5671 | 0.980 |
Why?
|
TOR Serine-Threonine Kinases | 11 | 2017 | 2057 | 0.970 |
Why?
|
Myeloid Differentiation Factor 88 | 7 | 2020 | 587 | 0.960 |
Why?
|
Thalidomide | 23 | 2015 | 885 | 0.960 |
Why?
|
Proto-Oncogene Proteins c-akt | 9 | 2014 | 2455 | 0.910 |
Why?
|
Cell Line, Tumor | 35 | 2024 | 16981 | 0.910 |
Why?
|
Mesenchymal Stem Cells | 6 | 2018 | 1642 | 0.850 |
Why?
|
Oligopeptides | 5 | 2019 | 1187 | 0.850 |
Why?
|
Prognosis | 38 | 2024 | 29625 | 0.850 |
Why?
|
Drug Resistance, Neoplasm | 16 | 2024 | 5305 | 0.840 |
Why?
|
Neoplasms, Experimental | 4 | 2018 | 1229 | 0.830 |
Why?
|
Hydroxamic Acids | 4 | 2014 | 481 | 0.800 |
Why?
|
Chromosome Aberrations | 9 | 2018 | 1768 | 0.800 |
Why?
|
Salvage Therapy | 9 | 2019 | 1264 | 0.800 |
Why?
|
Apoptosis | 22 | 2021 | 9486 | 0.790 |
Why?
|
Histone Deacetylase Inhibitors | 5 | 2015 | 774 | 0.780 |
Why?
|
Chemotaxis | 5 | 2014 | 598 | 0.760 |
Why?
|
Osteogenesis | 3 | 2018 | 1273 | 0.750 |
Why?
|
Precancerous Conditions | 4 | 2024 | 980 | 0.750 |
Why?
|
HMGA1a Protein | 1 | 2021 | 61 | 0.740 |
Why?
|
Xenograft Model Antitumor Assays | 9 | 2018 | 3602 | 0.730 |
Why?
|
Chymotrypsin | 2 | 2011 | 138 | 0.720 |
Why?
|
Aminopyridines | 2 | 2014 | 573 | 0.710 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2015 | 736 | 0.710 |
Why?
|
Animals | 78 | 2024 | 168459 | 0.700 |
Why?
|
Oligonucleotides | 2 | 2014 | 582 | 0.700 |
Why?
|
Protease Inhibitors | 7 | 2011 | 754 | 0.690 |
Why?
|
Dexamethasone | 17 | 2023 | 1948 | 0.690 |
Why?
|
Imidazoles | 5 | 2017 | 1180 | 0.690 |
Why?
|
RNA-Binding Proteins | 2 | 2021 | 1897 | 0.690 |
Why?
|
Cell Movement | 15 | 2021 | 5203 | 0.670 |
Why?
|
Mice | 54 | 2024 | 81525 | 0.670 |
Why?
|
Phosphatidylinositol 3-Kinases | 9 | 2014 | 2865 | 0.670 |
Why?
|
Clinical Trials as Topic | 17 | 2024 | 8002 | 0.660 |
Why?
|
Lymphoma, B-Cell | 6 | 2016 | 940 | 0.650 |
Why?
|
Immunoglobulin Light Chains | 3 | 2012 | 285 | 0.650 |
Why?
|
HSP90 Heat-Shock Proteins | 5 | 2008 | 424 | 0.650 |
Why?
|
Hematology | 3 | 2015 | 243 | 0.650 |
Why?
|
Phosphoramide Mustards | 1 | 2018 | 18 | 0.640 |
Why?
|
Mutation | 23 | 2024 | 30052 | 0.620 |
Why?
|
Tumor Cells, Cultured | 13 | 2021 | 6132 | 0.620 |
Why?
|
Lymphoma, Non-Hodgkin | 6 | 2017 | 1374 | 0.610 |
Why?
|
Heterocyclic Compounds | 5 | 2019 | 246 | 0.600 |
Why?
|
Cytokinesis | 1 | 2019 | 171 | 0.590 |
Why?
|
Receptor, Interferon alpha-beta | 1 | 2018 | 112 | 0.590 |
Why?
|
Phosphorylcholine | 6 | 2011 | 153 | 0.590 |
Why?
|
Nitroimidazoles | 1 | 2018 | 117 | 0.580 |
Why?
|
Disease-Free Survival | 17 | 2022 | 6814 | 0.580 |
Why?
|
Survival Analysis | 18 | 2020 | 10090 | 0.580 |
Why?
|
RNA Interference | 6 | 2016 | 2831 | 0.570 |
Why?
|
Immunologic Factors | 9 | 2022 | 1589 | 0.570 |
Why?
|
Quinolines | 3 | 2014 | 764 | 0.570 |
Why?
|
Female | 113 | 2024 | 392644 | 0.570 |
Why?
|
Transplantation, Autologous | 11 | 2023 | 2115 | 0.570 |
Why?
|
Cell Hypoxia | 4 | 2015 | 656 | 0.560 |
Why?
|
Cell Cycle | 12 | 2016 | 2932 | 0.550 |
Why?
|
Neovascularization, Pathologic | 4 | 2016 | 2645 | 0.550 |
Why?
|
Aged | 77 | 2024 | 169289 | 0.550 |
Why?
|
Hematologic Neoplasms | 6 | 2023 | 1896 | 0.540 |
Why?
|
Endothelial Cells | 10 | 2021 | 3548 | 0.540 |
Why?
|
Hematopoiesis | 6 | 2024 | 2049 | 0.540 |
Why?
|
Aged, 80 and over | 44 | 2020 | 58976 | 0.530 |
Why?
|
Exosomes | 4 | 2018 | 424 | 0.530 |
Why?
|
Middle Aged | 84 | 2024 | 220895 | 0.520 |
Why?
|
Genomic Instability | 1 | 2020 | 709 | 0.520 |
Why?
|
Signal Transduction | 29 | 2019 | 23445 | 0.520 |
Why?
|
Male | 101 | 2024 | 360804 | 0.520 |
Why?
|
Recurrence | 17 | 2019 | 8465 | 0.520 |
Why?
|
Stem Cell Transplantation | 8 | 2023 | 1600 | 0.510 |
Why?
|
Cell Survival | 12 | 2019 | 5791 | 0.510 |
Why?
|
Angiogenesis Inhibitors | 9 | 2015 | 2047 | 0.510 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2019 | 2872 | 0.500 |
Why?
|
Benzoxazoles | 1 | 2016 | 90 | 0.500 |
Why?
|
Enzyme Inhibitors | 7 | 2014 | 3712 | 0.490 |
Why?
|
Sarcoma, Myeloid | 1 | 2015 | 51 | 0.490 |
Why?
|
Stem Cell Niche | 2 | 2018 | 345 | 0.490 |
Why?
|
Adaptor Proteins, Signal Transducing | 4 | 2021 | 2898 | 0.480 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2014 | 87 | 0.470 |
Why?
|
Neoplasm Metastasis | 8 | 2019 | 4915 | 0.470 |
Why?
|
Pyrimidines | 6 | 2020 | 3028 | 0.460 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2021 | 3639 | 0.460 |
Why?
|
Lymphoma | 4 | 2024 | 1901 | 0.460 |
Why?
|
Coculture Techniques | 9 | 2017 | 1341 | 0.460 |
Why?
|
NF-kappa B | 8 | 2013 | 2490 | 0.450 |
Why?
|
Epigenesis, Genetic | 6 | 2024 | 3802 | 0.450 |
Why?
|
Treatment Outcome | 42 | 2019 | 64680 | 0.450 |
Why?
|
Glucocorticoid-Induced TNFR-Related Protein | 1 | 2013 | 39 | 0.440 |
Why?
|
Bone Neoplasms | 5 | 2017 | 2529 | 0.440 |
Why?
|
Genomics | 6 | 2024 | 5821 | 0.430 |
Why?
|
Multiprotein Complexes | 4 | 2017 | 1118 | 0.430 |
Why?
|
Maximum Tolerated Dose | 5 | 2019 | 883 | 0.430 |
Why?
|
Organ Transplantation | 3 | 2008 | 1157 | 0.430 |
Why?
|
Neoplastic Stem Cells | 5 | 2020 | 1347 | 0.420 |
Why?
|
Cell Transformation, Neoplastic | 6 | 2024 | 2825 | 0.420 |
Why?
|
Polyglycolic Acid | 1 | 2014 | 406 | 0.420 |
Why?
|
Clinical Trials, Phase II as Topic | 5 | 2022 | 629 | 0.420 |
Why?
|
Immunoglobulin G | 3 | 2021 | 4544 | 0.410 |
Why?
|
Psychology | 1 | 2014 | 356 | 0.400 |
Why?
|
Benzoquinones | 3 | 2008 | 198 | 0.400 |
Why?
|
Phagocytosis | 1 | 2018 | 1528 | 0.400 |
Why?
|
Drug Delivery Systems | 5 | 2014 | 2226 | 0.400 |
Why?
|
Flow Cytometry | 12 | 2022 | 5869 | 0.400 |
Why?
|
Interleukin-1beta | 1 | 2018 | 999 | 0.400 |
Why?
|
Lymphoma, Mantle-Cell | 4 | 2012 | 237 | 0.390 |
Why?
|
Immunotherapy | 5 | 2022 | 4652 | 0.390 |
Why?
|
Ephrin-B2 | 1 | 2011 | 40 | 0.390 |
Why?
|
Myeloma Proteins | 2 | 2011 | 71 | 0.390 |
Why?
|
Receptors, Eph Family | 1 | 2011 | 45 | 0.390 |
Why?
|
Polyethylene Glycols | 2 | 2014 | 1189 | 0.390 |
Why?
|
Gene Expression Profiling | 16 | 2024 | 9420 | 0.390 |
Why?
|
Benzylamines | 5 | 2019 | 247 | 0.390 |
Why?
|
Cadherins | 3 | 2012 | 903 | 0.390 |
Why?
|
Cells, Cultured | 16 | 2019 | 18965 | 0.380 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2012 | 686 | 0.380 |
Why?
|
Integrin alpha4beta1 | 2 | 2009 | 119 | 0.380 |
Why?
|
Antibodies, Viral | 2 | 2023 | 3156 | 0.380 |
Why?
|
Oligonucleotides, Antisense | 2 | 2012 | 461 | 0.370 |
Why?
|
Morpholines | 1 | 2014 | 581 | 0.370 |
Why?
|
Adult | 61 | 2024 | 221177 | 0.370 |
Why?
|
Lactams, Macrocyclic | 3 | 2008 | 318 | 0.370 |
Why?
|
Proteome | 2 | 2020 | 1862 | 0.370 |
Why?
|
Osteoclasts | 7 | 2016 | 711 | 0.360 |
Why?
|
Case-Control Studies | 12 | 2019 | 22176 | 0.360 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2011 | 106 | 0.360 |
Why?
|
Antibodies, Neoplasm | 3 | 2018 | 281 | 0.360 |
Why?
|
Blood Proteins | 1 | 2016 | 1173 | 0.360 |
Why?
|
Herpesvirus 4, Human | 2 | 2008 | 1078 | 0.360 |
Why?
|
Standard of Care | 1 | 2014 | 551 | 0.350 |
Why?
|
B-Lymphocytes | 8 | 2021 | 4758 | 0.350 |
Why?
|
Neoplasm Transplantation | 7 | 2019 | 2016 | 0.340 |
Why?
|
Oncogene Protein pp60(v-src) | 1 | 2009 | 75 | 0.340 |
Why?
|
Adenine | 6 | 2021 | 987 | 0.340 |
Why?
|
Transcriptional Activation | 2 | 2015 | 1756 | 0.340 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2021 | 9280 | 0.340 |
Why?
|
Oncogene Protein v-akt | 1 | 2009 | 129 | 0.340 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2011 | 175 | 0.330 |
Why?
|
Disease Management | 3 | 2019 | 2508 | 0.330 |
Why?
|
Gene Knockdown Techniques | 6 | 2018 | 1612 | 0.330 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2017 | 4575 | 0.330 |
Why?
|
Cryoglobulinemia | 2 | 2012 | 84 | 0.330 |
Why?
|
Antibodies | 4 | 2019 | 2418 | 0.330 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2021 | 1405 | 0.330 |
Why?
|
Extracellular Matrix | 1 | 2017 | 1726 | 0.330 |
Why?
|
Cell Differentiation | 13 | 2024 | 11528 | 0.320 |
Why?
|
Protein Kinases | 3 | 2020 | 1608 | 0.320 |
Why?
|
P-Selectin | 1 | 2011 | 597 | 0.320 |
Why?
|
Immune Tolerance | 1 | 2018 | 2303 | 0.320 |
Why?
|
Lymph Nodes | 4 | 2015 | 3466 | 0.320 |
Why?
|
Lactic Acid | 1 | 2014 | 1139 | 0.320 |
Why?
|
rac1 GTP-Binding Protein | 2 | 2011 | 242 | 0.320 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1998 | 0.320 |
Why?
|
Proto-Oncogene Proteins c-myc | 4 | 2018 | 988 | 0.320 |
Why?
|
T-Lymphocytes, Regulatory | 4 | 2018 | 3080 | 0.310 |
Why?
|
Drug Synergism | 5 | 2012 | 1755 | 0.310 |
Why?
|
Sequence Analysis, RNA | 4 | 2021 | 2020 | 0.310 |
Why?
|
Mutation, Missense | 2 | 2016 | 2571 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2012 | 727 | 0.300 |
Why?
|
Histone Acetyltransferases | 1 | 2010 | 336 | 0.300 |
Why?
|
Combined Modality Therapy | 9 | 2019 | 8529 | 0.300 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2009 | 234 | 0.300 |
Why?
|
Receptors, Chemokine | 3 | 2008 | 652 | 0.300 |
Why?
|
Receptor, IGF Type 1 | 2 | 2024 | 379 | 0.300 |
Why?
|
Dipeptides | 1 | 2010 | 391 | 0.300 |
Why?
|
Kaplan-Meier Estimate | 7 | 2019 | 6484 | 0.290 |
Why?
|
RNA, Neoplasm | 2 | 2016 | 750 | 0.290 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2022 | 3613 | 0.290 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18252 | 0.290 |
Why?
|
Survival Rate | 10 | 2021 | 12725 | 0.290 |
Why?
|
Germ-Line Mutation | 1 | 2016 | 1858 | 0.290 |
Why?
|
Administration, Oral | 7 | 2018 | 4021 | 0.290 |
Why?
|
beta 2-Microglobulin | 3 | 2019 | 329 | 0.280 |
Why?
|
Asymptomatic Diseases | 2 | 2021 | 588 | 0.280 |
Why?
|
Cell Communication | 5 | 2020 | 1657 | 0.280 |
Why?
|
Blood Platelets | 1 | 2018 | 2479 | 0.280 |
Why?
|
Nanoparticles | 2 | 2019 | 1959 | 0.280 |
Why?
|
Piperidines | 6 | 2021 | 1656 | 0.280 |
Why?
|
Bone Marrow Transplantation | 3 | 2018 | 2693 | 0.270 |
Why?
|
DNA Copy Number Variations | 4 | 2020 | 2020 | 0.270 |
Why?
|
Neoplasms, Second Primary | 3 | 2022 | 1052 | 0.270 |
Why?
|
Oligonucleotide Array Sequence Analysis | 5 | 2008 | 3778 | 0.270 |
Why?
|
Protein Array Analysis | 2 | 2005 | 400 | 0.270 |
Why?
|
Histone Deacetylases | 2 | 2010 | 719 | 0.270 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17904 | 0.270 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2020 | 2917 | 0.270 |
Why?
|
Clone Cells | 3 | 2024 | 1659 | 0.260 |
Why?
|
Graft vs Host Disease | 1 | 2018 | 3029 | 0.260 |
Why?
|
Lymphocytosis | 2 | 2023 | 121 | 0.260 |
Why?
|
Neoplasm Staging | 8 | 2019 | 11121 | 0.260 |
Why?
|
Retreatment | 2 | 2018 | 598 | 0.260 |
Why?
|
Drug Evaluation, Preclinical | 5 | 2018 | 1334 | 0.250 |
Why?
|
Models, Immunological | 2 | 2021 | 513 | 0.250 |
Why?
|
Chemokines, CXC | 1 | 2007 | 422 | 0.250 |
Why?
|
Kidney | 4 | 2022 | 7048 | 0.250 |
Why?
|
Cryoglobulins | 1 | 2004 | 58 | 0.240 |
Why?
|
Psychotherapy | 1 | 2014 | 1647 | 0.240 |
Why?
|
Bone and Bones | 2 | 2017 | 2568 | 0.240 |
Why?
|
Myelodysplastic Syndromes | 3 | 2023 | 1394 | 0.240 |
Why?
|
Panniculitis | 1 | 2005 | 45 | 0.240 |
Why?
|
Immunoblotting | 4 | 2014 | 1646 | 0.240 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2019 | 10766 | 0.240 |
Why?
|
Membrane Glycoproteins | 3 | 2011 | 3702 | 0.240 |
Why?
|
Models, Biological | 8 | 2020 | 9469 | 0.240 |
Why?
|
Immunotherapy, Adoptive | 2 | 2024 | 1469 | 0.240 |
Why?
|
Melphalan | 4 | 2022 | 420 | 0.230 |
Why?
|
Membrane Proteins | 4 | 2024 | 7856 | 0.230 |
Why?
|
Mechlorethamine | 1 | 2004 | 129 | 0.230 |
Why?
|
Cytogenetics | 2 | 2017 | 198 | 0.230 |
Why?
|
Hematologic Diseases | 3 | 2019 | 496 | 0.230 |
Why?
|
Repressor Proteins | 2 | 2017 | 2986 | 0.230 |
Why?
|
DNA Methylation | 3 | 2016 | 4398 | 0.230 |
Why?
|
Fibronectins | 4 | 2014 | 723 | 0.230 |
Why?
|
Immunosuppressive Agents | 5 | 2016 | 4174 | 0.230 |
Why?
|
Radioimmunotherapy | 1 | 2004 | 91 | 0.230 |
Why?
|
Epigenomics | 4 | 2016 | 943 | 0.230 |
Why?
|
Research Personnel | 1 | 2009 | 588 | 0.230 |
Why?
|
Genetic Testing | 1 | 2017 | 3537 | 0.220 |
Why?
|
Genome, Human | 2 | 2016 | 4425 | 0.220 |
Why?
|
Enzyme Activation | 4 | 2011 | 3597 | 0.220 |
Why?
|
Risk Factors | 17 | 2024 | 74206 | 0.220 |
Why?
|
Cell Line | 8 | 2020 | 15601 | 0.220 |
Why?
|
Killer Cells, Natural | 3 | 2024 | 2200 | 0.220 |
Why?
|
Tissue Scaffolds | 3 | 2016 | 934 | 0.220 |
Why?
|
Pyrazoles | 4 | 2020 | 2009 | 0.220 |
Why?
|
Blood Viscosity | 2 | 2017 | 124 | 0.220 |
Why?
|
Caregivers | 2 | 2022 | 2237 | 0.220 |
Why?
|
Fluorodeoxyglucose F18 | 2 | 2012 | 2010 | 0.220 |
Why?
|
Remission Induction | 9 | 2017 | 2396 | 0.220 |
Why?
|
Protein Kinase C | 2 | 2011 | 1202 | 0.220 |
Why?
|
Base Sequence | 3 | 2023 | 12441 | 0.220 |
Why?
|
Peripheral Nervous System Neoplasms | 1 | 2004 | 133 | 0.210 |
Why?
|
Mice, Inbred BALB C | 6 | 2018 | 6216 | 0.210 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2803 | 0.210 |
Why?
|
Proteomics | 5 | 2020 | 3849 | 0.210 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 1 | 2005 | 212 | 0.210 |
Why?
|
Transplantation Immunology | 1 | 2005 | 532 | 0.210 |
Why?
|
RNA, Messenger | 7 | 2020 | 12795 | 0.210 |
Why?
|
Mycosis Fungoides | 1 | 2024 | 170 | 0.210 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2003 | 225 | 0.200 |
Why?
|
Thiazoles | 1 | 2010 | 1517 | 0.200 |
Why?
|
Radiopharmaceuticals | 2 | 2012 | 2651 | 0.200 |
Why?
|
Career Choice | 1 | 2009 | 756 | 0.200 |
Why?
|
RNA Splice Sites | 1 | 2023 | 211 | 0.200 |
Why?
|
Stem Cells | 2 | 2018 | 3522 | 0.200 |
Why?
|
Neoplasm, Residual | 5 | 2021 | 1008 | 0.200 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2024 | 1349 | 0.200 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2008 | 612 | 0.200 |
Why?
|
Antibodies, Bispecific | 1 | 2024 | 196 | 0.200 |
Why?
|
RNA, Small Interfering | 4 | 2014 | 3429 | 0.190 |
Why?
|
Neoplasms | 7 | 2024 | 22170 | 0.190 |
Why?
|
Immunologic Tests | 1 | 2021 | 104 | 0.190 |
Why?
|
Proteasome Endopeptidase Complex | 4 | 2020 | 1320 | 0.190 |
Why?
|
Nephrotic Syndrome | 2 | 2022 | 390 | 0.180 |
Why?
|
Teaching | 1 | 2009 | 1170 | 0.180 |
Why?
|
Neoplasms, Plasma Cell | 1 | 2021 | 39 | 0.180 |
Why?
|
Sertoli Cells | 1 | 2020 | 50 | 0.180 |
Why?
|
Genetic Variation | 1 | 2016 | 6567 | 0.180 |
Why?
|
Prodrugs | 1 | 2023 | 261 | 0.180 |
Why?
|
Risk | 3 | 2022 | 9610 | 0.180 |
Why?
|
Scalp | 1 | 2004 | 389 | 0.180 |
Why?
|
Fingers | 1 | 2004 | 507 | 0.180 |
Why?
|
Sciatic Nerve | 1 | 2004 | 617 | 0.180 |
Why?
|
Chromosome Deletion | 3 | 2021 | 1386 | 0.180 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2004 | 646 | 0.180 |
Why?
|
Diphosphonates | 3 | 2017 | 636 | 0.180 |
Why?
|
Positron-Emission Tomography | 4 | 2015 | 6485 | 0.180 |
Why?
|
Quality of Life | 4 | 2024 | 13367 | 0.180 |
Why?
|
Follow-Up Studies | 13 | 2021 | 39106 | 0.170 |
Why?
|
Biopsy | 5 | 2019 | 6766 | 0.170 |
Why?
|
Microscopy, Confocal | 2 | 2019 | 1971 | 0.170 |
Why?
|
Isoenzymes | 2 | 2015 | 1687 | 0.170 |
Why?
|
Genes, ras | 1 | 2002 | 654 | 0.170 |
Why?
|
Drug Therapy, Combination | 5 | 2015 | 6310 | 0.170 |
Why?
|
Graft Survival | 2 | 2016 | 3819 | 0.170 |
Why?
|
Unfolded Protein Response | 2 | 2012 | 234 | 0.170 |
Why?
|
Bone Remodeling | 2 | 2014 | 581 | 0.170 |
Why?
|
ras Proteins | 2 | 2018 | 1054 | 0.170 |
Why?
|
Receptor, erbB-2 | 2 | 2024 | 2557 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-maf | 2 | 2017 | 69 | 0.170 |
Why?
|
Chromosomal Instability | 1 | 2020 | 178 | 0.170 |
Why?
|
Blotting, Western | 3 | 2011 | 5035 | 0.170 |
Why?
|
Thrombocythemia, Essential | 1 | 2020 | 113 | 0.160 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2013 | 1135 | 0.160 |
Why?
|
Hematopoietic Stem Cells | 5 | 2024 | 3396 | 0.160 |
Why?
|
Biomarkers, Pharmacological | 2 | 2010 | 161 | 0.160 |
Why?
|
Green Fluorescent Proteins | 3 | 2019 | 2065 | 0.160 |
Why?
|
Early Diagnosis | 1 | 2024 | 1186 | 0.160 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 2 | 2012 | 178 | 0.160 |
Why?
|
Graft vs Tumor Effect | 1 | 2018 | 68 | 0.160 |
Why?
|
Genes, myc | 2 | 2017 | 390 | 0.160 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2020 | 179 | 0.160 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 2 | 2011 | 441 | 0.160 |
Why?
|
Nitrogen Oxides | 1 | 2018 | 129 | 0.160 |
Why?
|
Nucleosides | 2 | 2009 | 131 | 0.150 |
Why?
|
Cell Growth Processes | 2 | 2011 | 384 | 0.150 |
Why?
|
Immunophenotyping | 4 | 2022 | 1870 | 0.150 |
Why?
|
Dioxygenases | 1 | 2020 | 345 | 0.150 |
Why?
|
Cytotoxins | 2 | 2009 | 153 | 0.150 |
Why?
|
Meningococcal Vaccines | 1 | 2018 | 94 | 0.150 |
Why?
|
Tumor Burden | 2 | 2014 | 1893 | 0.150 |
Why?
|
Antigens, Differentiation | 1 | 2020 | 910 | 0.150 |
Why?
|
Antibodies, Blocking | 1 | 2018 | 243 | 0.150 |
Why?
|
Proto-Oncogene Proteins | 3 | 2020 | 4511 | 0.150 |
Why?
|
Methotrexate | 1 | 2004 | 1719 | 0.140 |
Why?
|
Molecular Targeted Therapy | 3 | 2015 | 2811 | 0.140 |
Why?
|
Vidarabine | 4 | 2014 | 336 | 0.140 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 1745 | 0.140 |
Why?
|
Creatinine | 1 | 2023 | 1899 | 0.140 |
Why?
|
MAP Kinase Signaling System | 4 | 2008 | 1486 | 0.140 |
Why?
|
Mass Spectrometry | 2 | 2022 | 2192 | 0.140 |
Why?
|
Annexin A2 | 1 | 2017 | 44 | 0.140 |
Why?
|
Immunoenzyme Techniques | 2 | 2011 | 1705 | 0.140 |
Why?
|
Lactones | 2 | 2011 | 317 | 0.140 |
Why?
|
Patient Preference | 1 | 2024 | 924 | 0.140 |
Why?
|
Karyotyping | 2 | 2017 | 1171 | 0.140 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2018 | 303 | 0.140 |
Why?
|
Live Birth | 1 | 2020 | 511 | 0.140 |
Why?
|
Medical Oncology | 1 | 2009 | 2321 | 0.140 |
Why?
|
Cell Culture Techniques | 3 | 2019 | 1667 | 0.140 |
Why?
|
Lung | 2 | 2014 | 10000 | 0.140 |
Why?
|
Chemokines | 2 | 2014 | 960 | 0.140 |
Why?
|
Cyclin D1 | 2 | 2017 | 451 | 0.140 |
Why?
|
Proteins | 1 | 2011 | 6032 | 0.140 |
Why?
|
Cluster Analysis | 3 | 2016 | 2707 | 0.140 |
Why?
|
Neoplasm Invasiveness | 3 | 2014 | 3595 | 0.140 |
Why?
|
Skin Neoplasms | 3 | 2024 | 5821 | 0.140 |
Why?
|
Antimetabolites | 2 | 2014 | 128 | 0.140 |
Why?
|
Diploidy | 1 | 2016 | 132 | 0.140 |
Why?
|
Immunocompromised Host | 1 | 2021 | 856 | 0.130 |
Why?
|
Kidney Glomerulus | 1 | 2018 | 568 | 0.130 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2014 | 710 | 0.130 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2006 | 1640 | 0.130 |
Why?
|
Cell Count | 2 | 2017 | 1835 | 0.130 |
Why?
|
Genotype | 2 | 2024 | 12990 | 0.130 |
Why?
|
Receptors, Immunologic | 2 | 2021 | 1410 | 0.130 |
Why?
|
Galectin 1 | 1 | 2017 | 128 | 0.130 |
Why?
|
Granzymes | 1 | 2017 | 277 | 0.130 |
Why?
|
Silk | 1 | 2016 | 90 | 0.130 |
Why?
|
Organoids | 2 | 2019 | 740 | 0.130 |
Why?
|
Death, Sudden, Cardiac | 1 | 2004 | 1555 | 0.130 |
Why?
|
Bone Density Conservation Agents | 2 | 2014 | 795 | 0.130 |
Why?
|
Osteocytes | 1 | 2017 | 192 | 0.130 |
Why?
|
Lung Injury | 1 | 2020 | 422 | 0.130 |
Why?
|
Abortion, Spontaneous | 1 | 2020 | 533 | 0.130 |
Why?
|
Sulfonamides | 2 | 2020 | 1978 | 0.120 |
Why?
|
Connective Tissue | 1 | 2017 | 419 | 0.120 |
Why?
|
T-Lymphocytes | 7 | 2024 | 10194 | 0.120 |
Why?
|
Liver Diseases | 1 | 2004 | 1298 | 0.120 |
Why?
|
Fluorescent Antibody Technique | 2 | 2010 | 2469 | 0.120 |
Why?
|
Transplantation, Homologous | 5 | 2018 | 4806 | 0.120 |
Why?
|
E2F3 Transcription Factor | 1 | 2014 | 36 | 0.120 |
Why?
|
San Francisco | 1 | 2015 | 162 | 0.120 |
Why?
|
beta-Transducin Repeat-Containing Proteins | 1 | 2014 | 32 | 0.120 |
Why?
|
Embryo, Mammalian | 1 | 2020 | 1675 | 0.120 |
Why?
|
Retrospective Studies | 13 | 2023 | 80636 | 0.120 |
Why?
|
Hexokinase | 1 | 2015 | 124 | 0.120 |
Why?
|
Platelet Aggregation | 1 | 2018 | 771 | 0.120 |
Why?
|
Acetylation | 3 | 2016 | 1055 | 0.120 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2016 | 147 | 0.120 |
Why?
|
Podocytes | 1 | 2018 | 405 | 0.120 |
Why?
|
Platelet Activation | 1 | 2018 | 645 | 0.120 |
Why?
|
Paraproteins | 1 | 2014 | 38 | 0.120 |
Why?
|
Sialyltransferases | 1 | 2014 | 83 | 0.120 |
Why?
|
Drug Administration Schedule | 4 | 2018 | 4853 | 0.110 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2015 | 411 | 0.110 |
Why?
|
Chlorambucil | 2 | 2010 | 42 | 0.110 |
Why?
|
Cytokines | 6 | 2017 | 7396 | 0.110 |
Why?
|
Leukemia, T-Cell | 2 | 2004 | 101 | 0.110 |
Why?
|
Transendothelial and Transepithelial Migration | 1 | 2014 | 100 | 0.110 |
Why?
|
Cladribine | 2 | 2010 | 34 | 0.110 |
Why?
|
Gene Expression | 7 | 2018 | 7581 | 0.110 |
Why?
|
Antigens, CD20 | 2 | 2005 | 200 | 0.110 |
Why?
|
Fatigue | 3 | 2022 | 1552 | 0.110 |
Why?
|
GTP Phosphohydrolases | 1 | 2017 | 517 | 0.110 |
Why?
|
Small Molecule Libraries | 1 | 2019 | 733 | 0.110 |
Why?
|
Alkylating Agents | 1 | 2014 | 133 | 0.110 |
Why?
|
Genetic Markers | 2 | 2017 | 2601 | 0.110 |
Why?
|
Induced Pluripotent Stem Cells | 2 | 2022 | 1860 | 0.110 |
Why?
|
Time Factors | 6 | 2019 | 39967 | 0.110 |
Why?
|
Pyrroles | 2 | 2011 | 1125 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 546 | 0.110 |
Why?
|
Alendronate | 1 | 2014 | 175 | 0.110 |
Why?
|
Diagnosis, Differential | 4 | 2012 | 12974 | 0.110 |
Why?
|
Luminescent Measurements | 1 | 2014 | 342 | 0.110 |
Why?
|
Azacitidine | 1 | 2014 | 336 | 0.100 |
Why?
|
Genetic Heterogeneity | 1 | 2016 | 732 | 0.100 |
Why?
|
Anti-HIV Agents | 1 | 2009 | 4527 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2024 | 2449 | 0.100 |
Why?
|
Platelet Count | 2 | 2020 | 781 | 0.100 |
Why?
|
Carbohydrates | 1 | 2015 | 390 | 0.100 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22169 | 0.100 |
Why?
|
Postoperative Complications | 2 | 2005 | 15631 | 0.100 |
Why?
|
Karyopherins | 1 | 2013 | 132 | 0.100 |
Why?
|
Practice Guidelines as Topic | 2 | 2011 | 7390 | 0.100 |
Why?
|
Cell Division | 3 | 2009 | 4465 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3084 | 0.100 |
Why?
|
Osteonecrosis | 1 | 2014 | 229 | 0.100 |
Why?
|
Gene Silencing | 3 | 2017 | 1509 | 0.100 |
Why?
|
Plasmacytoma | 3 | 2021 | 171 | 0.100 |
Why?
|
Chromatin | 1 | 2024 | 2960 | 0.100 |
Why?
|
Phenotype | 4 | 2022 | 16591 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3204 | 0.100 |
Why?
|
Incidence | 6 | 2015 | 21353 | 0.100 |
Why?
|
Neovascularization, Physiologic | 2 | 2011 | 1349 | 0.100 |
Why?
|
Mucin-1 | 1 | 2017 | 540 | 0.100 |
Why?
|
Early Detection of Cancer | 2 | 2024 | 3201 | 0.100 |
Why?
|
Pluripotent Stem Cells | 1 | 2019 | 799 | 0.100 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1787 | 0.100 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2017 | 842 | 0.100 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2014 | 718 | 0.100 |
Why?
|
Clodronic Acid | 1 | 2011 | 59 | 0.100 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2016 | 699 | 0.100 |
Why?
|
Mannans | 1 | 2011 | 58 | 0.100 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2021 | 2273 | 0.100 |
Why?
|
Lymphocyte Count | 2 | 2004 | 778 | 0.100 |
Why?
|
Culture Media, Conditioned | 1 | 2013 | 522 | 0.100 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11903 | 0.100 |
Why?
|
Interleukin-6 | 4 | 2010 | 3208 | 0.100 |
Why?
|
beta Catenin | 2 | 2014 | 1040 | 0.090 |
Why?
|
Polymers | 1 | 2018 | 1617 | 0.090 |
Why?
|
Stomatitis | 1 | 2014 | 271 | 0.090 |
Why?
|
Mice, Transgenic | 3 | 2019 | 9539 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 619 | 0.090 |
Why?
|
beta-Glucans | 1 | 2011 | 123 | 0.090 |
Why?
|
Gastrointestinal Diseases | 1 | 2019 | 1200 | 0.090 |
Why?
|
Integrin beta Chains | 1 | 2011 | 115 | 0.090 |
Why?
|
Glycolipids | 1 | 2011 | 206 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2008 | 1405 | 0.090 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2735 | 0.090 |
Why?
|
Prospective Studies | 8 | 2021 | 54425 | 0.090 |
Why?
|
Glycolysis | 1 | 2015 | 835 | 0.090 |
Why?
|
Data Collection | 1 | 2020 | 3322 | 0.090 |
Why?
|
Translocation, Genetic | 1 | 2016 | 1393 | 0.090 |
Why?
|
DNA Fragmentation | 1 | 2011 | 237 | 0.090 |
Why?
|
Cell Physiological Phenomena | 1 | 2011 | 150 | 0.090 |
Why?
|
Blood Coagulation Factors | 1 | 2012 | 365 | 0.090 |
Why?
|
DNA-Binding Proteins | 2 | 2020 | 9606 | 0.090 |
Why?
|
Immunohistochemistry | 4 | 2018 | 11076 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2008 | 473 | 0.090 |
Why?
|
Down-Regulation | 3 | 2007 | 2919 | 0.090 |
Why?
|
Cytogenetic Analysis | 1 | 2011 | 270 | 0.090 |
Why?
|
Gene Dosage | 2 | 2012 | 1217 | 0.090 |
Why?
|
Drug Monitoring | 1 | 2016 | 962 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 2 | 2008 | 477 | 0.090 |
Why?
|
Lymphocytes | 2 | 2008 | 2612 | 0.090 |
Why?
|
Aspirin | 1 | 2021 | 3133 | 0.090 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2014 | 1171 | 0.080 |
Why?
|
Osteolysis | 1 | 2011 | 275 | 0.080 |
Why?
|
Metformin | 1 | 2017 | 906 | 0.080 |
Why?
|
Cell Tracking | 1 | 2011 | 139 | 0.080 |
Why?
|
Protein Biosynthesis | 2 | 2018 | 2113 | 0.080 |
Why?
|
Risk Assessment | 3 | 2020 | 23995 | 0.080 |
Why?
|
Secondary Prevention | 1 | 2016 | 1475 | 0.080 |
Why?
|
Ribosomal Protein S6 | 1 | 2009 | 71 | 0.080 |
Why?
|
Phosphorylation | 3 | 2011 | 8320 | 0.080 |
Why?
|
Cyclophosphamide | 1 | 2015 | 2218 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 1551 | 0.080 |
Why?
|
Immunoprecipitation | 1 | 2011 | 878 | 0.080 |
Why?
|
Adipocytes | 1 | 2016 | 1194 | 0.080 |
Why?
|
Diagnostic Imaging | 2 | 2014 | 3530 | 0.080 |
Why?
|
Benzodioxoles | 1 | 2009 | 75 | 0.080 |
Why?
|
Phosphoproteins | 2 | 2023 | 2448 | 0.080 |
Why?
|
Job Application | 1 | 2009 | 38 | 0.080 |
Why?
|
Severity of Illness Index | 2 | 2019 | 15842 | 0.080 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2011 | 426 | 0.080 |
Why?
|
Microscopy, Fluorescence | 2 | 2019 | 2645 | 0.080 |
Why?
|
Tunicamycin | 1 | 2008 | 108 | 0.080 |
Why?
|
Colony-Forming Units Assay | 1 | 2009 | 352 | 0.080 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2010 | 431 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2004 | 3164 | 0.080 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4111 | 0.080 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2013 | 857 | 0.080 |
Why?
|
CpG Islands | 1 | 2013 | 1230 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 3 | 2016 | 1844 | 0.080 |
Why?
|
Mycoses | 1 | 2011 | 386 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4414 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 2 | 2008 | 615 | 0.080 |
Why?
|
Financial Support | 1 | 2009 | 117 | 0.080 |
Why?
|
Health Status Disparities | 1 | 2020 | 1852 | 0.080 |
Why?
|
Research Design | 1 | 2024 | 6180 | 0.080 |
Why?
|
Liver | 1 | 2004 | 7529 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2008 | 191 | 0.070 |
Why?
|
Genes, Regulator | 1 | 2009 | 373 | 0.070 |
Why?
|
Drug Resistance | 1 | 2014 | 1596 | 0.070 |
Why?
|
Caspases | 1 | 2011 | 879 | 0.070 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2013 | 499 | 0.070 |
Why?
|
Mice, Nude | 1 | 2014 | 3615 | 0.070 |
Why?
|
Hematocrit | 1 | 2009 | 623 | 0.070 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 678 | 0.070 |
Why?
|
Central Nervous System | 1 | 2015 | 1336 | 0.070 |
Why?
|
Stress, Physiological | 2 | 2012 | 1403 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 3612 | 0.070 |
Why?
|
Janus Kinase 2 | 2 | 2024 | 560 | 0.070 |
Why?
|
International Agencies | 1 | 2008 | 243 | 0.070 |
Why?
|
Adiposity | 1 | 2017 | 1878 | 0.070 |
Why?
|
Lymphoma, Follicular | 1 | 2012 | 457 | 0.070 |
Why?
|
Central Nervous System Neoplasms | 1 | 2015 | 916 | 0.070 |
Why?
|
Financing, Organized | 1 | 2009 | 204 | 0.070 |
Why?
|
Stilbenes | 1 | 2008 | 155 | 0.070 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2007 | 92 | 0.070 |
Why?
|
Quinazolines | 2 | 2014 | 1371 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2017 | 2057 | 0.070 |
Why?
|
Diarrhea | 1 | 2014 | 1318 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2004 | 4249 | 0.070 |
Why?
|
Hemoglobins | 2 | 2015 | 1525 | 0.070 |
Why?
|
Histones | 3 | 2016 | 2580 | 0.070 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2014 | 3810 | 0.070 |
Why?
|
Monitoring, Physiologic | 1 | 2014 | 1779 | 0.070 |
Why?
|
Authorship | 1 | 2010 | 284 | 0.070 |
Why?
|
Hepatitis C Antibodies | 1 | 2007 | 146 | 0.070 |
Why?
|
Herpes Zoster | 1 | 2009 | 253 | 0.070 |
Why?
|
Amyloid | 1 | 2012 | 841 | 0.070 |
Why?
|
DNA Replication | 2 | 2018 | 1418 | 0.070 |
Why?
|
Femur | 1 | 2013 | 1307 | 0.070 |
Why?
|
Prevalence | 2 | 2022 | 15732 | 0.070 |
Why?
|
Career Mobility | 1 | 2009 | 259 | 0.070 |
Why?
|
Double-Blind Method | 1 | 2020 | 12341 | 0.070 |
Why?
|
Nitrophenols | 1 | 2006 | 169 | 0.070 |
Why?
|
Boston | 1 | 2019 | 9326 | 0.070 |
Why?
|
Inhibitory Concentration 50 | 1 | 2007 | 465 | 0.070 |
Why?
|
Tissue Engineering | 1 | 2016 | 1868 | 0.070 |
Why?
|
Macrophages | 2 | 2018 | 5769 | 0.070 |
Why?
|
Renal Insufficiency | 1 | 2012 | 809 | 0.070 |
Why?
|
Software | 1 | 2020 | 4434 | 0.060 |
Why?
|
Chromosomes, Human, Pair 13 | 2 | 2021 | 192 | 0.060 |
Why?
|
Lentivirus | 1 | 2009 | 508 | 0.060 |
Why?
|
Vaccination | 1 | 2018 | 3384 | 0.060 |
Why?
|
Mitochondria | 1 | 2019 | 3624 | 0.060 |
Why?
|
Simvastatin | 1 | 2008 | 346 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2425 | 0.060 |
Why?
|
Cohort Studies | 3 | 2022 | 41487 | 0.060 |
Why?
|
Transplantation, Heterologous | 3 | 2011 | 2385 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 687 | 0.060 |
Why?
|
Minnesota | 1 | 2006 | 338 | 0.060 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2007 | 332 | 0.060 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2024 | 1351 | 0.060 |
Why?
|
Myeloid Progenitor Cells | 1 | 2005 | 113 | 0.060 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2006 | 367 | 0.060 |
Why?
|
Amyloidosis | 1 | 2012 | 817 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2014 | 4278 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2009 | 1126 | 0.060 |
Why?
|
Granulation Tissue | 1 | 2004 | 92 | 0.060 |
Why?
|
Family | 1 | 2016 | 3194 | 0.060 |
Why?
|
Fractures, Bone | 1 | 2017 | 2046 | 0.060 |
Why?
|
bcl-X Protein | 1 | 2006 | 410 | 0.060 |
Why?
|
Conflict of Interest | 1 | 2010 | 554 | 0.060 |
Why?
|
Leukemia, Prolymphocytic | 1 | 2004 | 7 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 974 | 0.060 |
Why?
|
Leg Ulcer | 1 | 2004 | 71 | 0.060 |
Why?
|
ADP-ribosyl Cyclase | 1 | 2004 | 38 | 0.060 |
Why?
|
Interferon-alpha | 1 | 2009 | 921 | 0.060 |
Why?
|
Infusions, Intravenous | 2 | 2011 | 2219 | 0.060 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1265 | 0.060 |
Why?
|
Immunologic Memory | 2 | 2024 | 1359 | 0.060 |
Why?
|
Radiography | 2 | 2015 | 6965 | 0.060 |
Why?
|
Zebrafish | 1 | 2016 | 3007 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2004 | 6403 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3358 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2009 | 1246 | 0.060 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2005 | 192 | 0.060 |
Why?
|
Disclosure | 1 | 2010 | 748 | 0.060 |
Why?
|
Bone Density | 1 | 2017 | 3551 | 0.060 |
Why?
|
Interleukin-17 | 1 | 2010 | 912 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3575 | 0.060 |
Why?
|
Genome, Mitochondrial | 1 | 2024 | 66 | 0.060 |
Why?
|
Interleukin-3 | 1 | 2005 | 425 | 0.060 |
Why?
|
Antigens, CD19 | 1 | 2007 | 424 | 0.060 |
Why?
|
PTEN Phosphohydrolase | 1 | 2009 | 1115 | 0.060 |
Why?
|
Kinetics | 2 | 2019 | 6374 | 0.060 |
Why?
|
Birds | 1 | 2004 | 168 | 0.060 |
Why?
|
Genome | 1 | 2012 | 1740 | 0.060 |
Why?
|
Pneumonia | 1 | 2015 | 2143 | 0.050 |
Why?
|
Drug Discovery | 1 | 2011 | 1051 | 0.050 |
Why?
|
Biomedical Research | 2 | 2010 | 3429 | 0.050 |
Why?
|
Goals | 1 | 2009 | 711 | 0.050 |
Why?
|
Cytoskeletal Proteins | 1 | 2009 | 1342 | 0.050 |
Why?
|
Universities | 1 | 2009 | 993 | 0.050 |
Why?
|
Sequence Analysis, DNA | 2 | 2012 | 4740 | 0.050 |
Why?
|
Mentors | 1 | 2009 | 661 | 0.050 |
Why?
|
Drug Industry | 1 | 2010 | 788 | 0.050 |
Why?
|
Yttrium Radioisotopes | 1 | 2004 | 107 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8654 | 0.050 |
Why?
|
Genes, Immunoglobulin | 1 | 2004 | 285 | 0.050 |
Why?
|
DNA | 1 | 2017 | 7212 | 0.050 |
Why?
|
Teratogens | 1 | 2003 | 117 | 0.050 |
Why?
|
Nucleocapsid | 1 | 2023 | 63 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2016 | 3233 | 0.050 |
Why?
|
Farnesyltranstransferase | 1 | 2002 | 71 | 0.050 |
Why?
|
Societies, Medical | 1 | 2015 | 3905 | 0.050 |
Why?
|
Protein Prenylation | 1 | 2002 | 70 | 0.050 |
Why?
|
Breast Neoplasms | 2 | 2024 | 21012 | 0.050 |
Why?
|
Mice, Knockout | 1 | 2018 | 14414 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15266 | 0.050 |
Why?
|
Mice, Inbred NOD | 1 | 2007 | 1827 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2008 | 1134 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2003 | 397 | 0.050 |
Why?
|
Cell Death | 1 | 2008 | 1678 | 0.050 |
Why?
|
Alkyl and Aryl Transferases | 1 | 2002 | 86 | 0.050 |
Why?
|
Injections, Intravenous | 1 | 2004 | 1379 | 0.050 |
Why?
|
Decision Trees | 1 | 2004 | 504 | 0.050 |
Why?
|
Algorithms | 1 | 2023 | 14031 | 0.050 |
Why?
|
Lymphatic Diseases | 1 | 2004 | 320 | 0.050 |
Why?
|
Autophagy | 1 | 2010 | 1326 | 0.050 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1934 | 0.050 |
Why?
|
Cytoskeleton | 1 | 2007 | 1170 | 0.050 |
Why?
|
Bilirubin | 1 | 2004 | 436 | 0.050 |
Why?
|
Antigens, CD34 | 1 | 2024 | 658 | 0.050 |
Why?
|
Benzimidazoles | 1 | 2007 | 858 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5789 | 0.050 |
Why?
|
DNA Modification Methylases | 1 | 2022 | 210 | 0.050 |
Why?
|
Diet | 1 | 2020 | 8075 | 0.050 |
Why?
|
Biphenyl Compounds | 1 | 2006 | 1007 | 0.050 |
Why?
|
Publishing | 1 | 2009 | 833 | 0.050 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2009 | 4352 | 0.050 |
Why?
|
Lymphoma, T-Cell | 1 | 2004 | 304 | 0.050 |
Why?
|
DNA, Neoplasm | 2 | 2017 | 1745 | 0.050 |
Why?
|
Pain | 2 | 2014 | 5073 | 0.050 |
Why?
|
Epidemiologic Methods | 1 | 2006 | 1336 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 2 | 2015 | 1974 | 0.050 |
Why?
|
Antigens, CD | 3 | 2006 | 4003 | 0.050 |
Why?
|
Transfection | 1 | 2009 | 5774 | 0.050 |
Why?
|
Alkaline Phosphatase | 1 | 2004 | 864 | 0.050 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2895 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2017 | 14605 | 0.040 |
Why?
|
Vasculitis | 1 | 2004 | 521 | 0.040 |
Why?
|
Diterpenes | 1 | 2021 | 171 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2004 | 1031 | 0.040 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2023 | 421 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2011 | 3448 | 0.040 |
Why?
|
Obesity | 2 | 2024 | 12947 | 0.040 |
Why?
|
Megakaryocytes | 1 | 2024 | 566 | 0.040 |
Why?
|
Tissue Culture Techniques | 1 | 2020 | 290 | 0.040 |
Why?
|
Hepacivirus | 1 | 2007 | 1336 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2006 | 1651 | 0.040 |
Why?
|
Protein Binding | 1 | 2011 | 9351 | 0.040 |
Why?
|
Ecosystem | 1 | 2023 | 490 | 0.040 |
Why?
|
Young Adult | 3 | 2020 | 59243 | 0.040 |
Why?
|
Periodicals as Topic | 1 | 2010 | 1463 | 0.040 |
Why?
|
Statistics as Topic | 1 | 2005 | 2358 | 0.040 |
Why?
|
Gene Deletion | 2 | 2021 | 2665 | 0.040 |
Why?
|
RNA Splicing | 1 | 2023 | 918 | 0.040 |
Why?
|
Databases, Protein | 1 | 2020 | 387 | 0.040 |
Why?
|
B-Cell Maturation Antigen | 1 | 2019 | 149 | 0.040 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 1991 | 899 | 0.040 |
Why?
|
Carrier Proteins | 1 | 2011 | 4936 | 0.040 |
Why?
|
Up-Regulation | 1 | 2007 | 4124 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2009 | 2759 | 0.040 |
Why?
|
RNA, Viral | 1 | 2007 | 2846 | 0.040 |
Why?
|
Chromosome Disorders | 1 | 2021 | 497 | 0.040 |
Why?
|
Advisory Committees | 1 | 2022 | 787 | 0.040 |
Why?
|
Sequence Analysis | 1 | 2018 | 240 | 0.040 |
Why?
|
Myeloproliferative Disorders | 1 | 2024 | 613 | 0.040 |
Why?
|
Multigene Family | 1 | 2021 | 1076 | 0.040 |
Why?
|
Nephrons | 1 | 2019 | 168 | 0.040 |
Why?
|
Comparative Genomic Hybridization | 2 | 2009 | 473 | 0.040 |
Why?
|
Staining and Labeling | 1 | 2022 | 1085 | 0.040 |
Why?
|
Drug Design | 1 | 2002 | 1048 | 0.040 |
Why?
|
Laminin | 1 | 2018 | 408 | 0.040 |
Why?
|
Pathology, Molecular | 1 | 2020 | 328 | 0.030 |
Why?
|
Fluorescence | 1 | 2019 | 756 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2016 | 15936 | 0.030 |
Why?
|
Bone Resorption | 2 | 2014 | 723 | 0.030 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3688 | 0.030 |
Why?
|
Interferon Regulatory Factors | 1 | 2018 | 261 | 0.030 |
Why?
|
Plasmapheresis | 1 | 2017 | 206 | 0.030 |
Why?
|
Hepatitis C | 1 | 2007 | 1584 | 0.030 |
Why?
|
Organelle Size | 1 | 2016 | 6 | 0.030 |
Why?
|
World Health Organization | 1 | 2022 | 1322 | 0.030 |
Why?
|
Albumins | 1 | 2019 | 575 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 3 | 2019 | 36426 | 0.030 |
Why?
|
Hodgkin Disease | 1 | 2004 | 1378 | 0.030 |
Why?
|
Trans-Activators | 1 | 2005 | 2856 | 0.030 |
Why?
|
Bombyx | 1 | 2016 | 58 | 0.030 |
Why?
|
Macrophage Colony-Stimulating Factor | 2 | 2007 | 186 | 0.030 |
Why?
|
Serpins | 1 | 2017 | 247 | 0.030 |
Why?
|
Ultrafiltration | 1 | 2016 | 49 | 0.030 |
Why?
|
Administration, Cutaneous | 1 | 2018 | 713 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 379 | 0.030 |
Why?
|
Ultracentrifugation | 1 | 2016 | 183 | 0.030 |
Why?
|
RNA, Bacterial | 1 | 2017 | 393 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2265 | 0.030 |
Why?
|
Dendritic Cells | 2 | 2017 | 2747 | 0.030 |
Why?
|
Angiogenic Proteins | 1 | 2016 | 101 | 0.030 |
Why?
|
Caspase 3 | 1 | 2017 | 731 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2009 | 10209 | 0.030 |
Why?
|
X-Ray Microtomography | 1 | 2017 | 456 | 0.030 |
Why?
|
Biological Products | 1 | 2024 | 914 | 0.030 |
Why?
|
Wnt Proteins | 1 | 2019 | 718 | 0.030 |
Why?
|
Transcription Factors | 1 | 2014 | 12128 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2004 | 1880 | 0.030 |
Why?
|
Nitrogen Mustard Compounds | 1 | 2014 | 44 | 0.030 |
Why?
|
Adipose Tissue, White | 1 | 2017 | 365 | 0.030 |
Why?
|
Gadolinium | 1 | 2019 | 960 | 0.030 |
Why?
|
Leucine | 1 | 2016 | 548 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20098 | 0.030 |
Why?
|
Molecular Structure | 1 | 2018 | 1880 | 0.030 |
Why?
|
Proline | 1 | 2016 | 457 | 0.030 |
Why?
|
Anoikis | 1 | 2014 | 48 | 0.030 |
Why?
|
RNA | 1 | 2024 | 2726 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2017 | 983 | 0.030 |
Why?
|
N-Acetylneuraminic Acid | 1 | 2014 | 174 | 0.030 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2014 | 168 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2017 | 1039 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 3 | 2012 | 20570 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 3245 | 0.030 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2012 | 91 | 0.030 |
Why?
|
United States | 3 | 2020 | 72334 | 0.030 |
Why?
|
Densitometry | 1 | 2012 | 151 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3123 | 0.030 |
Why?
|
Bone Marrow Examination | 1 | 2012 | 154 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 871 | 0.030 |
Why?
|
Tacrolimus | 1 | 2016 | 733 | 0.030 |
Why?
|
Adolescent | 3 | 2005 | 88319 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2020 | 1733 | 0.030 |
Why?
|
Organ Size | 1 | 2017 | 2254 | 0.030 |
Why?
|
Doxorubicin | 1 | 2019 | 2224 | 0.020 |
Why?
|
Glycosylation | 1 | 2015 | 1098 | 0.020 |
Why?
|
Viscera | 1 | 2012 | 138 | 0.020 |
Why?
|
Neutropenia | 1 | 2017 | 885 | 0.020 |
Why?
|
Receptors, Interleukin-2 | 2 | 1991 | 562 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 1991 | 2547 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2016 | 1738 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2017 | 1738 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2017 | 1188 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2020 | 1897 | 0.020 |
Why?
|
Focal Adhesion Kinase 1 | 1 | 2011 | 120 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 26125 | 0.020 |
Why?
|
Collagen Type I | 1 | 2014 | 616 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2019 | 2526 | 0.020 |
Why?
|
Galactose | 1 | 2011 | 297 | 0.020 |
Why?
|
Sumoylation | 1 | 2011 | 83 | 0.020 |
Why?
|
Serum | 1 | 2011 | 209 | 0.020 |
Why?
|
Joints | 1 | 2012 | 322 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2638 | 0.020 |
Why?
|
Nurses | 1 | 2020 | 2478 | 0.020 |
Why?
|
Transcription Factor RelA | 1 | 2011 | 254 | 0.020 |
Why?
|
Receptors, Interleukin-17 | 1 | 2010 | 82 | 0.020 |
Why?
|
Inflammation | 2 | 2024 | 10773 | 0.020 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2009 | 38 | 0.020 |
Why?
|
Azepines | 1 | 2011 | 329 | 0.020 |
Why?
|
Syndrome | 1 | 2015 | 3267 | 0.020 |
Why?
|
Fluorine Radioisotopes | 1 | 2012 | 418 | 0.020 |
Why?
|
Age Factors | 1 | 2006 | 18395 | 0.020 |
Why?
|
Sensation Disorders | 1 | 2010 | 160 | 0.020 |
Why?
|
Electrophoresis, Capillary | 1 | 2009 | 63 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2017 | 1181 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1902 | 0.020 |
Why?
|
Proteoglycans | 1 | 2011 | 803 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2011 | 535 | 0.020 |
Why?
|
Drug Administration Routes | 1 | 2008 | 150 | 0.020 |
Why?
|
Polysaccharides | 1 | 2015 | 1014 | 0.020 |
Why?
|
Body Composition | 1 | 2017 | 2426 | 0.020 |
Why?
|
Metabolomics | 1 | 2017 | 1659 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2019 | 3113 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2012 | 947 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2008 | 138 | 0.020 |
Why?
|
Lymphocyte Activation | 2 | 1991 | 5486 | 0.020 |
Why?
|
Anemia | 1 | 2017 | 1509 | 0.020 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2011 | 617 | 0.020 |
Why?
|
Prednisone | 1 | 2012 | 1563 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2021 | 12463 | 0.020 |
Why?
|
Public Health | 1 | 2020 | 2669 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2009 | 662 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2012 | 1154 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2645 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2022 | 4481 | 0.020 |
Why?
|
Contrast Media | 1 | 2019 | 5311 | 0.020 |
Why?
|
Triazoles | 1 | 2011 | 903 | 0.020 |
Why?
|
Child | 2 | 2022 | 80153 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2007 | 326 | 0.020 |
Why?
|
RANK Ligand | 1 | 2007 | 318 | 0.020 |
Why?
|
Benzodiazepines | 1 | 2011 | 1132 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2019 | 7594 | 0.020 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2005 | 203 | 0.020 |
Why?
|
Th1 Cells | 1 | 2010 | 1036 | 0.020 |
Why?
|
Protein Folding | 1 | 2008 | 870 | 0.010 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 823 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 3792 | 0.010 |
Why?
|
Graft Rejection | 1 | 2017 | 4445 | 0.010 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2008 | 621 | 0.010 |
Why?
|
Insulin | 1 | 2018 | 6596 | 0.010 |
Why?
|
Forecasting | 1 | 2012 | 2928 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2850 | 0.010 |
Why?
|
Physician's Role | 1 | 2010 | 917 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8124 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2017 | 4234 | 0.010 |
Why?
|
Peptides | 1 | 2014 | 4358 | 0.010 |
Why?
|
Models, Statistical | 1 | 2016 | 5079 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2006 | 2510 | 0.010 |
Why?
|
Infant | 1 | 2022 | 36192 | 0.010 |
Why?
|
Ligands | 1 | 2007 | 3272 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2011 | 3492 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2009 | 2161 | 0.010 |
Why?
|
Leukocytes | 1 | 2008 | 2026 | 0.010 |
Why?
|
Venous Thromboembolism | 1 | 2012 | 1866 | 0.010 |
Why?
|
Echocardiography | 1 | 2012 | 4989 | 0.010 |
Why?
|
Myocardium | 1 | 2012 | 4726 | 0.010 |
Why?
|
Heart | 1 | 2012 | 4404 | 0.010 |
Why?
|
Interleukin-2 | 1 | 1986 | 1889 | 0.010 |
Why?
|
Pregnancy | 1 | 2020 | 29874 | 0.010 |
Why?
|
Alleles | 1 | 2009 | 6863 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2006 | 2822 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2011 | 5796 | 0.010 |
Why?
|
Renal Dialysis | 1 | 1986 | 1797 | 0.010 |
Why?
|
Piperazines | 1 | 2006 | 2523 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 1986 | 2471 | 0.010 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1990 | 445 | 0.000 |
Why?
|
Phytohemagglutinins | 1 | 1986 | 167 | 0.000 |
Why?
|
Brain | 1 | 2012 | 27112 | 0.000 |
Why?
|
Reference Values | 1 | 1986 | 4920 | 0.000 |
Why?
|